Geldanamycin- FITC

Hsp90 fluorescent probe

Catalog No. SIH-113

5 out of 5 based on 1 customer rating
CAS No. 30562-34-6
Molecular Formula C55H63N5O13S
SKU: SIH-113 Categories: ,

Clear
SIH-113_Geldanamycin_FITC_Chemical_Structure.png
Product Name Geldanamycin- FITC
Description

Hsp90 fluorescent probe

Purity >97% (TLC), NMR conforms
CAS No. 30562-34-6
Molecular Formula C55H63N5O13S
Molecular Weight 1034.2
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Solubility May be dissolved in DMSO (>10 mg/ml)
Source Synthetic
Appearance Purple Solid
SMILES C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)/C)OC)OC(=O)N)C)C)O)OC
InChI InChI=1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)
InChIKey QTQAWLPCGQOSGP-KSRBKZBZSA-N
Safety Phrases Classification: Harmful. May be harmful if inhaled, swallowed or absorbed through skin.
Safety Phrases:
S22 - Do not breathe dust
S24/25 - Avoid contact with skin and eyes
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Risk Phrases:
R68- Possible risk of irreversible effects
Cite This Product Geldanamycin- FITC (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-113)

Biological Description

Alternative Names (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1] docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Research Areas Cancer, Heat Shock
PubChem ID Geldanamycin: 5288382
Scientific Background Geldanamycin is a benzoquinoid ansamycin produced by Streptomyces hygroscopicus. It binds specifically to heat shock protein HSP90 and downregulates target proteins including tyrosine kinases, steroid receptors, transcription factors and cell cycle regulatory kinases (1,2). It induces the inactivation, destabilization and eventual degradation of HIF-1α (3). It is also an inhibitor of pp60src tyrosine kinase and of c-myc gene expression in murine lymphoblastoma cells. It inhibits the transforming activity of abl, erbB, fps, src, and yes (4). Geldanamycin is capable of destabilizing several oncogene and proto-oncogene products; it is a potent inhibitor of the nuclear hormone receptor family (5). It protects against α-synuclein toxicity to dopaminergic neurons in Drosophila, and destabilizes mutant p53 protein from a number of breast, leukemic, and prostate cell lines (6). Inhibits basal and hypoxia-induced expression of c-Jun (IC50=75nM) and abolishes hypoxia-induced increase in c-Jun N-terminal kinase (JNK) activity. Inhibits telomerase activity through inhibition of HSP90, a chaperone required for the assembly and activation of telomerase in human cells (6). It is ~10-fold more potent than herbimycin A. Specifically, the geldanamycin fluorescent probe may be used for detection of cell surface Hsp90, may be used in fluorescence polarization assays, and characterizations of geldanamycin drug-target interactions.
References 1. Whitesell L., et al. (1994) Proc. Natl. Acad. Sci. USA 91:8324.
2. Neckers L. (2002) Trends Mol. Med. 8: S55.
3. Mabjeesh N.J., et al. (2002) Cancer Res. 62: 2478.
4. Chavany C., et al. 1996) Amer. Society Biochem Mol Bio. 9: 4974-4977.
5. Villa R., et al. (2003) Carcinogenesis. 24(5): 851-9.
6. Yamaki H., Iguchi-Ariga S.M., and Ariga H. (1989) J Antibiot (Tokyo). 42(4): 604-10.

Product Images

<p>Chemical structure of Geldanamycin- FITC (SIH-113), a Hsp90 Fluorescent Probe. Molecular Formula: C55H63N5O13S. Molecular Weight: 1034.2 g/mol.</p>

Chemical structure of Geldanamycin- FITC (SIH-113), a Hsp90 Fluorescent Probe. Molecular Formula: C55H63N5O13S. Molecular Weight: 1034.2 g/mol.

Reviews

1 review for Geldanamycin- FITC

  1. 5 out of 5

    :

    Based on validation through cited publications.

Add a review

Your email address will not be published. Required fields are marked *